Moderna
MRNA
#290
Rank
C$113.14 B
Marketcap
C$279.63
Share price
-2.17%
Change (1 day)
720.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$113.14 Billion

As of November 2026 Moderna has a market cap of C$113.14 Billion. This makes Moderna the world's 290th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026C$113.14 B577.71%
2025C$16.69 B-24.66%
2024C$22.16 B-55.94%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Moderna was reported to be:

C$113.14 Billion
by Nasdaq info icon info icon
C$113.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$933.68 B 725.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$407.51 B 260.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$472.72 B 317.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$0.81 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.27 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$1.19 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$27.62 B-75.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$8.38 B-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA